Small Cap-Biotech’s "nuclear winter" is over-firms can now tap the equity capital markets again, and big pharma is shopping for acquisitions. Risk aversion remains low however: buyers want companies with proven products in major, undertreated diseases.
(較少)
Dec. 24 (Bloomberg) — Laszlo Birinyi, president of Birinyi Associates Inc., talks with Bloomberg’s Scarlet Fu about the outlook for the U.S. equity market. Birinyi also discusses investors' return to the stock market, economic and market trends, and investment strategy. (Source: Bloomberg)
(較少)
Dec. 24 (Bloomberg) — Michael Pond, interest rate strategist at Barclays Capital, talks with Bloomberg’s Scarlet Fu about the Federal Reserves purchase of Treasury notes and the impact on the yield curve.¶ Pond also discusses the outlook for the dollar, U.S. Treasury bond auction and inves...
(較少)
Safe Search Filter is ON. Truveo understands that some content may not be appropriate for all users. We provide a Safe Search Filter so that you can choose the content best suited to your personal interest. Turning OFF the Safe Search Filter may display content that is only suitable for viewers over 18 years of age. Click the button below if you are over 18 and would like to turn OFF the Safe Search Filter.